Current Atherosclerosis Reports·Oct 26Targeting Apolipoprotein C-III in Hypertriglyceridemia: Implications for Pancreatitis and Cardiovascular riskReviewSevere hypertriglyceridemiaPaper
Monaldi Archives for Chest Disease·Feb 27Efficacy and safety of antisense oligonucleotide therapies targeting APoC-III in patients with severe hypertriglyceridemia: a meta-analysis of randomized controlled trialsMeta-analysis of randomized trialsHypertriglyceridemiaPaper
Archives of Medical Science·Feb 122025: The year in cardiovascular disease - the year of triglyceride lowering therapies. Can we effectively reduce triglyceride-related residual cardiovascular disease and pancreatitis risk?ReviewAcute pancreatitisPaper
Pharmacological Reviews·Jan 30From physiopathology to treatment of familial hypercholesterolemia: Existing and emerging pharmacotherapiesReviewPharmacotherapyPaper